---
title: CDMO Daily News — September 6, 2026
slug: daily-news-2026-09-06-cdmo
site: cdmo
post_kind: news
byline: BioBM
description: September 6 CDMO daily: Northway Biotech Opens €61M Cell Therapy CDMO in Vilnius with 20 cGMP Lines — Northway Biotech's Vilnius facility adds 20 parallel…
canonical_url: https://www.cdmo.directory/posts/daily-news-2026-09-06-cdmo
published_at: 2026-09-06T00:00:06.618Z
last_updated: 2026-09-06T00:00:52.980Z
---

### [Northway Biotech](/companies/northway-biotech) Opens €61M Cell Therapy CDMO in Vilnius with 20 cGMP Lines
- [Northway Biotech](/companies/northway-biotech) inaugurated a 3,500-square-meter cell therapy CDMO facility in Vilnius, Lithuania, backed by €61 million investment from Northway Group.
- The center operates up to 20 independent cGMP manufacturing lines for autologous and allogeneic [cell therapies](/companies/celltherapies), personalized vaccines, and regenerative medicine, with first customers already contracted.
- Facility includes segregated manufacturing infrastructure, quality control labs, and cleanroom systems designed to handle multiple cell-based products in parallel while maintaining contamination control.

**Operational Impact**

[Northway Biotech](/companies/northway-biotech)'s Vilnius facility adds 20 parallel cGMP cell-therapy manufacturing lines in Eastern Europe with immediate customer demand, expanding regional capacity for autologous/allogeneic therapies and personalized vaccines.

*Source: [PharmaSource RSS](https://pharmasource.global/content/news/cdmo-news/northway-biotech-opens-70-94m-cell-therapy-cdmo-in-lithuania)*

## References

1. [PharmaSource RSS — Northway Biotech Opens €61M Cell Therapy CDMO in Vilnius with 20 cGMP Lines](https://pharmasource.global/content/news/cdmo-news/northway-biotech-opens-70-94m-cell-therapy-cdmo-in-lithuania)

Source: https://www.cdmo.directory/posts/daily-news-2026-09-06-cdmo